The global market for Desmopressin Acetate API is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Desmopressin Acetate API market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Desmopressin Acetate API market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Desmopressin Acetate API market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Desmopressin Acetate API market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Desmopressin Acetate API players cover Bachem Americas, Teva Pharmaceutical Industries, BCN Peptides SA, ScinoPharm Taiwan and Hemmo Pharmaceuticals, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Desmopressin Acetate API market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Desmopressin Acetate API market, with both quantitative and qualitative data, to help readers understand how the Desmopressin Acetate API market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in Tons.
Market Segmentation:
The study segments the Desmopressin Acetate API market and forecasts the market size by Type (Purity Above 98% and Purity Below 98%,), by Application (Tablets and Injection.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Purity Above 98%
Purity Below 98%
Segmentation by application
Tablets
Injection
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Bachem Americas
Teva Pharmaceutical Industries
BCN Peptides SA
ScinoPharm Taiwan
Hemmo Pharmaceuticals
Polypeptide Laboratories Sweden AB
Auro Peptides
Hybio Pharmaceutical
Hainan Zhonghe Pharmaceutical
Nanjing Xingyin Pharmaceutical
Suzhou Tianma Pharma Group
Chapter Introduction
Chapter 1: Scope of Desmopressin Acetate API, Research Methodology, etc.
Chapter 2: Executive Summary, global Desmopressin Acetate API market size (sales and revenue) and CAGR, Desmopressin Acetate API market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Desmopressin Acetate API sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Desmopressin Acetate API sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Desmopressin Acetate API market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Bachem Americas, Teva Pharmaceutical Industries, BCN Peptides SA, ScinoPharm Taiwan, Hemmo Pharmaceuticals, Polypeptide Laboratories Sweden AB, Auro Peptides, Hybio Pharmaceutical and Hainan Zhonghe Pharmaceutical, etc.
Chapter 14: Research Findings and Conclusion
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Desmopressin Acetate API Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Desmopressin Acetate API by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Desmopressin Acetate API by Country/Region, 2017, 2022 & 2028
2.2 Desmopressin Acetate API Segment by Type
2.2.1 Purity Above 98%
2.2.2 Purity Below 98%
2.3 Desmopressin Acetate API Sales by Type
2.3.1 Global Desmopressin Acetate API Sales Market Share by Type (2017-2022)
2.3.2 Global Desmopressin Acetate API Revenue and Market Share by Type (2017-2022)
2.3.3 Global Desmopressin Acetate API Sale Price by Type (2017-2022)
2.4 Desmopressin Acetate API Segment by Application
2.4.1 Tablets
2.4.2 Injection
2.5 Desmopressin Acetate API Sales by Application
2.5.1 Global Desmopressin Acetate API Sale Market Share by Application (2017-2022)
2.5.2 Global Desmopressin Acetate API Revenue and Market Share by Application (2017-2022)
2.5.3 Global Desmopressin Acetate API Sale Price by Application (2017-2022)
3 Global Desmopressin Acetate API by Company
3.1 Global Desmopressin Acetate API Breakdown Data by Company
3.1.1 Global Desmopressin Acetate API Annual Sales by Company (2020-2022)
3.1.2 Global Desmopressin Acetate API Sales Market Share by Company (2020-2022)
3.2 Global Desmopressin Acetate API Annual Revenue by Company (2020-2022)
3.2.1 Global Desmopressin Acetate API Revenue by Company (2020-2022)
3.2.2 Global Desmopressin Acetate API Revenue Market Share by Company (2020-2022)
3.3 Global Desmopressin Acetate API Sale Price by Company
3.4 Key Manufacturers Desmopressin Acetate API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Desmopressin Acetate API Product Location Distribution
3.4.2 Players Desmopressin Acetate API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Desmopressin Acetate API by Geographic Region
4.1 World Historic Desmopressin Acetate API Market Size by Geographic Region (2017-2022)
4.1.1 Global Desmopressin Acetate API Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Desmopressin Acetate API Annual Revenue by Geographic Region
4.2 World Historic Desmopressin Acetate API Market Size by Country/Region (2017-2022)
4.2.1 Global Desmopressin Acetate API Annual Sales by Country/Region (2017-2022)
4.2.2 Global Desmopressin Acetate API Annual Revenue by Country/Region
4.3 Americas Desmopressin Acetate API Sales Growth
4.4 APAC Desmopressin Acetate API Sales Growth
4.5 Europe Desmopressin Acetate API Sales Growth
4.6 Middle East & Africa Desmopressin Acetate API Sales Growth
5 Americas
5.1 Americas Desmopressin Acetate API Sales by Country
5.1.1 Americas Desmopressin Acetate API Sales by Country (2017-2022)
5.1.2 Americas Desmopressin Acetate API Revenue by Country (2017-2022)
5.2 Americas Desmopressin Acetate API Sales by Type
5.3 Americas Desmopressin Acetate API Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Desmopressin Acetate API Sales by Region
6.1.1 APAC Desmopressin Acetate API Sales by Region (2017-2022)
6.1.2 APAC Desmopressin Acetate API Revenue by Region (2017-2022)
6.2 APAC Desmopressin Acetate API Sales by Type
6.3 APAC Desmopressin Acetate API Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Desmopressin Acetate API by Country
7.1.1 Europe Desmopressin Acetate API Sales by Country (2017-2022)
7.1.2 Europe Desmopressin Acetate API Revenue by Country (2017-2022)
7.2 Europe Desmopressin Acetate API Sales by Type
7.3 Europe Desmopressin Acetate API Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Desmopressin Acetate API by Country
8.1.1 Middle East & Africa Desmopressin Acetate API Sales by Country (2017-2022)
8.1.2 Middle East & Africa Desmopressin Acetate API Revenue by Country (2017-2022)
8.2 Middle East & Africa Desmopressin Acetate API Sales by Type
8.3 Middle East & Africa Desmopressin Acetate API Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Desmopressin Acetate API
10.3 Manufacturing Process Analysis of Desmopressin Acetate API
10.4 Industry Chain Structure of Desmopressin Acetate API
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Desmopressin Acetate API Distributors
11.3 Desmopressin Acetate API Customer
12 World Forecast Review for Desmopressin Acetate API by Geographic Region
12.1 Global Desmopressin Acetate API Market Size Forecast by Region
12.1.1 Global Desmopressin Acetate API Forecast by Region (2023-2028)
12.1.2 Global Desmopressin Acetate API Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Desmopressin Acetate API Forecast by Type
12.7 Global Desmopressin Acetate API Forecast by Application
13 Key Players Analysis
13.1 Bachem Americas
13.1.1 Bachem Americas Company Information
13.1.2 Bachem Americas Desmopressin Acetate API Product Offered
13.1.3 Bachem Americas Desmopressin Acetate API Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Bachem Americas Main Business Overview
13.1.5 Bachem Americas Latest Developments
13.2 Teva Pharmaceutical Industries
13.2.1 Teva Pharmaceutical Industries Company Information
13.2.2 Teva Pharmaceutical Industries Desmopressin Acetate API Product Offered
13.2.3 Teva Pharmaceutical Industries Desmopressin Acetate API Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Teva Pharmaceutical Industries Main Business Overview
13.2.5 Teva Pharmaceutical Industries Latest Developments
13.3 BCN Peptides SA
13.3.1 BCN Peptides SA Company Information
13.3.2 BCN Peptides SA Desmopressin Acetate API Product Offered
13.3.3 BCN Peptides SA Desmopressin Acetate API Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 BCN Peptides SA Main Business Overview
13.3.5 BCN Peptides SA Latest Developments
13.4 ScinoPharm Taiwan
13.4.1 ScinoPharm Taiwan Company Information
13.4.2 ScinoPharm Taiwan Desmopressin Acetate API Product Offered
13.4.3 ScinoPharm Taiwan Desmopressin Acetate API Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 ScinoPharm Taiwan Main Business Overview
13.4.5 ScinoPharm Taiwan Latest Developments
13.5 Hemmo Pharmaceuticals
13.5.1 Hemmo Pharmaceuticals Company Information
13.5.2 Hemmo Pharmaceuticals Desmopressin Acetate API Product Offered
13.5.3 Hemmo Pharmaceuticals Desmopressin Acetate API Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Hemmo Pharmaceuticals Main Business Overview
13.5.5 Hemmo Pharmaceuticals Latest Developments
13.6 Polypeptide Laboratories Sweden AB
13.6.1 Polypeptide Laboratories Sweden AB Company Information
13.6.2 Polypeptide Laboratories Sweden AB Desmopressin Acetate API Product Offered
13.6.3 Polypeptide Laboratories Sweden AB Desmopressin Acetate API Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Polypeptide Laboratories Sweden AB Main Business Overview
13.6.5 Polypeptide Laboratories Sweden AB Latest Developments
13.7 Auro Peptides
13.7.1 Auro Peptides Company Information
13.7.2 Auro Peptides Desmopressin Acetate API Product Offered
13.7.3 Auro Peptides Desmopressin Acetate API Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Auro Peptides Main Business Overview
13.7.5 Auro Peptides Latest Developments
13.8 Hybio Pharmaceutical
13.8.1 Hybio Pharmaceutical Company Information
13.8.2 Hybio Pharmaceutical Desmopressin Acetate API Product Offered
13.8.3 Hybio Pharmaceutical Desmopressin Acetate API Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Hybio Pharmaceutical Main Business Overview
13.8.5 Hybio Pharmaceutical Latest Developments
13.9 Hainan Zhonghe Pharmaceutical
13.9.1 Hainan Zhonghe Pharmaceutical Company Information
13.9.2 Hainan Zhonghe Pharmaceutical Desmopressin Acetate API Product Offered
13.9.3 Hainan Zhonghe Pharmaceutical Desmopressin Acetate API Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Hainan Zhonghe Pharmaceutical Main Business Overview
13.9.5 Hainan Zhonghe Pharmaceutical Latest Developments
13.10 Nanjing Xingyin Pharmaceutical
13.10.1 Nanjing Xingyin Pharmaceutical Company Information
13.10.2 Nanjing Xingyin Pharmaceutical Desmopressin Acetate API Product Offered
13.10.3 Nanjing Xingyin Pharmaceutical Desmopressin Acetate API Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Nanjing Xingyin Pharmaceutical Main Business Overview
13.10.5 Nanjing Xingyin Pharmaceutical Latest Developments
13.11 Suzhou Tianma Pharma Group
13.11.1 Suzhou Tianma Pharma Group Company Information
13.11.2 Suzhou Tianma Pharma Group Desmopressin Acetate API Product Offered
13.11.3 Suzhou Tianma Pharma Group Desmopressin Acetate API Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Suzhou Tianma Pharma Group Main Business Overview
13.11.5 Suzhou Tianma Pharma Group Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Desmopressin Acetate API Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Desmopressin Acetate API Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Purity Above 98%
Table 4. Major Players of Purity Below 98%
Table 5. Global Desmopressin Acetate API Sales by Type (2017-2022) & (Tons)
Table 6. Global Desmopressin Acetate API Sales Market Share by Type (2017-2022)
Table 7. Global Desmopressin Acetate API Revenue by Type (2017-2022) & ($ million)
Table 8. Global Desmopressin Acetate API Revenue Market Share by Type (2017-2022)
Table 9. Global Desmopressin Acetate API Sale Price by Type (2017-2022) & (US$/Ton)
Table 10. Global Desmopressin Acetate API Sales by Application (2017-2022) & (Tons)
Table 11. Global Desmopressin Acetate API Sales Market Share by Application (2017-2022)
Table 12. Global Desmopressin Acetate API Revenue by Application (2017-2022)
Table 13. Global Desmopressin Acetate API Revenue Market Share by Application (2017-2022)
Table 14. Global Desmopressin Acetate API Sale Price by Application (2017-2022) & (US$/Ton)
Table 15. Global Desmopressin Acetate API Sales by Company (2020-2022) & (Tons)
Table 16. Global Desmopressin Acetate API Sales Market Share by Company (2020-2022)
Table 17. Global Desmopressin Acetate API Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Desmopressin Acetate API Revenue Market Share by Company (2020-2022)
Table 19. Global Desmopressin Acetate API Sale Price by Company (2020-2022) & (US$/Ton)
Table 20. Key Manufacturers Desmopressin Acetate API Producing Area Distribution and Sales Area
Table 21. Players Desmopressin Acetate API Products Offered
Table 22. Desmopressin Acetate API Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Desmopressin Acetate API Sales by Geographic Region (2017-2022) & (Tons)
Table 26. Global Desmopressin Acetate API Sales Market Share Geographic Region (2017-2022)
Table 27. Global Desmopressin Acetate API Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Desmopressin Acetate API Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Desmopressin Acetate API Sales by Country/Region (2017-2022) & (Tons)
Table 30. Global Desmopressin Acetate API Sales Market Share by Country/Region (2017-2022)
Table 31. Global Desmopressin Acetate API Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Desmopressin Acetate API Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Desmopressin Acetate API Sales by Country (2017-2022) & (Tons)
Table 34. Americas Desmopressin Acetate API Sales Market Share by Country (2017-2022)
Table 35. Americas Desmopressin Acetate API Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Desmopressin Acetate API Revenue Market Share by Country (2017-2022)
Table 37. Americas Desmopressin Acetate API Sales by Type (2017-2022) & (Tons)
Table 38. Americas Desmopressin Acetate API Sales Market Share by Type (2017-2022)
Table 39. Americas Desmopressin Acetate API Sales by Application (2017-2022) & (Tons)
Table 40. Americas Desmopressin Acetate API Sales Market Share by Application (2017-2022)
Table 41. APAC Desmopressin Acetate API Sales by Region (2017-2022) & (Tons)
Table 42. APAC Desmopressin Acetate API Sales Market Share by Region (2017-2022)
Table 43. APAC Desmopressin Acetate API Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Desmopressin Acetate API Revenue Market Share by Region (2017-2022)
Table 45. APAC Desmopressin Acetate API Sales by Type (2017-2022) & (Tons)
Table 46. APAC Desmopressin Acetate API Sales Market Share by Type (2017-2022)
Table 47. APAC Desmopressin Acetate API Sales by Application (2017-2022) & (Tons)
Table 48. APAC Desmopressin Acetate API Sales Market Share by Application (2017-2022)
Table 49. Europe Desmopressin Acetate API Sales by Country (2017-2022) & (Tons)
Table 50. Europe Desmopressin Acetate API Sales Market Share by Country (2017-2022)
Table 51. Europe Desmopressin Acetate API Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Desmopressin Acetate API Revenue Market Share by Country (2017-2022)
Table 53. Europe Desmopressin Acetate API Sales by Type (2017-2022) & (Tons)
Table 54. Europe Desmopressin Acetate API Sales Market Share by Type (2017-2022)
Table 55. Europe Desmopressin Acetate API Sales by Application (2017-2022) & (Tons)
Table 56. Europe Desmopressin Acetate API Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Desmopressin Acetate API Sales by Country (2017-2022) & (Tons)
Table 58. Middle East & Africa Desmopressin Acetate API Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Desmopressin Acetate API Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Desmopressin Acetate API Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Desmopressin Acetate API Sales by Type (2017-2022) & (Tons)
Table 62. Middle East & Africa Desmopressin Acetate API Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Desmopressin Acetate API Sales by Application (2017-2022) & (Tons)
Table 64. Middle East & Africa Desmopressin Acetate API Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Desmopressin Acetate API
Table 66. Key Market Challenges & Risks of Desmopressin Acetate API
Table 67. Key Industry Trends of Desmopressin Acetate API
Table 68. Desmopressin Acetate API Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Desmopressin Acetate API Distributors List
Table 71. Desmopressin Acetate API Customer List
Table 72. Global Desmopressin Acetate API Sales Forecast by Region (2023-2028) & (Tons)
Table 73. Global Desmopressin Acetate API Sales Market Forecast by Region
Table 74. Global Desmopressin Acetate API Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Desmopressin Acetate API Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Desmopressin Acetate API Sales Forecast by Country (2023-2028) & (Tons)
Table 77. Americas Desmopressin Acetate API Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Desmopressin Acetate API Sales Forecast by Region (2023-2028) & (Tons)
Table 79. APAC Desmopressin Acetate API Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Desmopressin Acetate API Sales Forecast by Country (2023-2028) & (Tons)
Table 81. Europe Desmopressin Acetate API Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Desmopressin Acetate API Sales Forecast by Country (2023-2028) & (Tons)
Table 83. Middle East & Africa Desmopressin Acetate API Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Desmopressin Acetate API Sales Forecast by Type (2023-2028) & (Tons)
Table 85. Global Desmopressin Acetate API Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Desmopressin Acetate API Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Desmopressin Acetate API Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Desmopressin Acetate API Sales Forecast by Application (2023-2028) & (Tons)
Table 89. Global Desmopressin Acetate API Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Desmopressin Acetate API Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Desmopressin Acetate API Revenue Market Share Forecast by Application (2023-2028)
Table 92. Bachem Americas Basic Information, Desmopressin Acetate API Manufacturing Base, Sales Area and Its Competitors
Table 93. Bachem Americas Desmopressin Acetate API Product Offered
Table 94. Bachem Americas Desmopressin Acetate API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 95. Bachem Americas Main Business
Table 96. Bachem Americas Latest Developments
Table 97. Teva Pharmaceutical Industries Basic Information, Desmopressin Acetate API Manufacturing Base, Sales Area and Its Competitors
Table 98. Teva Pharmaceutical Industries Desmopressin Acetate API Product Offered
Table 99. Teva Pharmaceutical Industries Desmopressin Acetate API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 100. Teva Pharmaceutical Industries Main Business
Table 101. Teva Pharmaceutical Industries Latest Developments
Table 102. BCN Peptides SA Basic Information, Desmopressin Acetate API Manufacturing Base, Sales Area and Its Competitors
Table 103. BCN Peptides SA Desmopressin Acetate API Product Offered
Table 104. BCN Peptides SA Desmopressin Acetate API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 105. BCN Peptides SA Main Business
Table 106. BCN Peptides SA Latest Developments
Table 107. ScinoPharm Taiwan Basic Information, Desmopressin Acetate API Manufacturing Base, Sales Area and Its Competitors
Table 108. ScinoPharm Taiwan Desmopressin Acetate API Product Offered
Table 109. ScinoPharm Taiwan Desmopressin Acetate API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 110. ScinoPharm Taiwan Main Business
Table 111. ScinoPharm Taiwan Latest Developments
Table 112. Hemmo Pharmaceuticals Basic Information, Desmopressin Acetate API Manufacturing Base, Sales Area and Its Competitors
Table 113. Hemmo Pharmaceuticals Desmopressin Acetate API Product Offered
Table 114. Hemmo Pharmaceuticals Desmopressin Acetate API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 115. Hemmo Pharmaceuticals Main Business
Table 116. Hemmo Pharmaceuticals Latest Developments
Table 117. Polypeptide Laboratories Sweden AB Basic Information, Desmopressin Acetate API Manufacturing Base, Sales Area and Its Competitors
Table 118. Polypeptide Laboratories Sweden AB Desmopressin Acetate API Product Offered
Table 119. Polypeptide Laboratories Sweden AB Desmopressin Acetate API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 120. Polypeptide Laboratories Sweden AB Main Business
Table 121. Polypeptide Laboratories Sweden AB Latest Developments
Table 122. Auro Peptides Basic Information, Desmopressin Acetate API Manufacturing Base, Sales Area and Its Competitors
Table 123. Auro Peptides Desmopressin Acetate API Product Offered
Table 124. Auro Peptides Desmopressin Acetate API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 125. Auro Peptides Main Business
Table 126. Auro Peptides Latest Developments
Table 127. Hybio Pharmaceutical Basic Information, Desmopressin Acetate API Manufacturing Base, Sales Area and Its Competitors
Table 128. Hybio Pharmaceutical Desmopressin Acetate API Product Offered
Table 129. Hybio Pharmaceutical Desmopressin Acetate API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 130. Hybio Pharmaceutical Main Business
Table 131. Hybio Pharmaceutical Latest Developments
Table 132. Hainan Zhonghe Pharmaceutical Basic Information, Desmopressin Acetate API Manufacturing Base, Sales Area and Its Competitors
Table 133. Hainan Zhonghe Pharmaceutical Desmopressin Acetate API Product Offered
Table 134. Hainan Zhonghe Pharmaceutical Desmopressin Acetate API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 135. Hainan Zhonghe Pharmaceutical Main Business
Table 136. Hainan Zhonghe Pharmaceutical Latest Developments
Table 137. Nanjing Xingyin Pharmaceutical Basic Information, Desmopressin Acetate API Manufacturing Base, Sales Area and Its Competitors
Table 138. Nanjing Xingyin Pharmaceutical Desmopressin Acetate API Product Offered
Table 139. Nanjing Xingyin Pharmaceutical Desmopressin Acetate API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 140. Nanjing Xingyin Pharmaceutical Main Business
Table 141. Nanjing Xingyin Pharmaceutical Latest Developments
Table 142. Suzhou Tianma Pharma Group Basic Information, Desmopressin Acetate API Manufacturing Base, Sales Area and Its Competitors
Table 143. Suzhou Tianma Pharma Group Desmopressin Acetate API Product Offered
Table 144. Suzhou Tianma Pharma Group Desmopressin Acetate API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 145. Suzhou Tianma Pharma Group Main Business
Table 146. Suzhou Tianma Pharma Group Latest Developments
List of Figures
Figure 1. Picture of Desmopressin Acetate API
Figure 2. Desmopressin Acetate API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Desmopressin Acetate API Sales Growth Rate 2017-2028 (Tons)
Figure 7. Global Desmopressin Acetate API Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Desmopressin Acetate API Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Purity Above 98%
Figure 10. Product Picture of Purity Below 98%
Figure 11. Global Desmopressin Acetate API Sales Market Share by Type in 2021
Figure 12. Global Desmopressin Acetate API Revenue Market Share by Type (2017-2022)
Figure 13. Desmopressin Acetate API Consumed in Tablets
Figure 14. Global Desmopressin Acetate API Market: Tablets (2017-2022) & (Tons)
Figure 15. Desmopressin Acetate API Consumed in Injection
Figure 16. Global Desmopressin Acetate API Market: Injection (2017-2022) & (Tons)
Figure 17. Global Desmopressin Acetate API Sales Market Share by Application (2017-2022)
Figure 18. Global Desmopressin Acetate API Revenue Market Share by Application in 2021
Figure 19. Desmopressin Acetate API Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Desmopressin Acetate API Revenue Market Share by Company in 2021
Figure 21. Global Desmopressin Acetate API Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Desmopressin Acetate API Revenue Market Share by Geographic Region in 2021
Figure 23. Global Desmopressin Acetate API Sales Market Share by Region (2017-2022)
Figure 24. Global Desmopressin Acetate API Revenue Market Share by Country/Region in 2021
Figure 25. Americas Desmopressin Acetate API Sales 2017-2022 (Tons)
Figure 26. Americas Desmopressin Acetate API Revenue 2017-2022 ($ Millions)
Figure 27. APAC Desmopressin Acetate API Sales 2017-2022 (Tons)
Figure 28. APAC Desmopressin Acetate API Revenue 2017-2022 ($ Millions)
Figure 29. Europe Desmopressin Acetate API Sales 2017-2022 (Tons)
Figure 30. Europe Desmopressin Acetate API Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Desmopressin Acetate API Sales 2017-2022 (Tons)
Figure 32. Middle East & Africa Desmopressin Acetate API Revenue 2017-2022 ($ Millions)
Figure 33. Americas Desmopressin Acetate API Sales Market Share by Country in 2021
Figure 34. Americas Desmopressin Acetate API Revenue Market Share by Country in 2021
Figure 35. United States Desmopressin Acetate API Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Desmopressin Acetate API Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Desmopressin Acetate API Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Desmopressin Acetate API Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Desmopressin Acetate API Sales Market Share by Region in 2021
Figure 40. APAC Desmopressin Acetate API Revenue Market Share by Regions in 2021
Figure 41. China Desmopressin Acetate API Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Desmopressin Acetate API Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Desmopressin Acetate API Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Desmopressin Acetate API Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Desmopressin Acetate API Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Desmopressin Acetate API Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Desmopressin Acetate API Sales Market Share by Country in 2021
Figure 48. Europe Desmopressin Acetate API Revenue Market Share by Country in 2021
Figure 49. Germany Desmopressin Acetate API Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Desmopressin Acetate API Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Desmopressin Acetate API Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Desmopressin Acetate API Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Desmopressin Acetate API Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Desmopressin Acetate API Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Desmopressin Acetate API Revenue Market Share by Country in 2021
Figure 56. Egypt Desmopressin Acetate API Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Desmopressin Acetate API Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Desmopressin Acetate API Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Desmopressin Acetate API Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Desmopressin Acetate API Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Desmopressin Acetate API in 2021
Figure 62. Manufacturing Process Analysis of Desmopressin Acetate API
Figure 63. Industry Chain Structure of Desmopressin Acetate API
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles